Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat

Cancer Research

Volumn 56, Issue 13, 1996, Pages 2985-2991

  Sargent, Linda ^a,c   Dragan, Yvonne ^a   Xu, Yi Hua ^a   Sattler, Gerald ^a   Wiley, John ^b   Pitot, Henry C ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; NITROSOUREA DERIVATIVE; PHENOBARBITAL;

ANEUPLOIDY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; CHROMOSOME 3P; CHROMOSOME 6Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FEMALE; GENE; GENE DOSAGE; GENETIC STABILITY; KARYOTYPE; LIVER CARCINOGENESIS; LIVER CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENS; DIETHYLNITROSAMINE; DIPLOIDY; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; KARYOTYPING; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029891201     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Rowley, J Chromosome abnormalities in cancer. Cancer Genet. Cytogenet., 2: 175-198, 1980.
2. Mitelman, F. and Hein, S. Consistent involvement of only 71 of the 329 chromosomal bands of the human genome in primary neoplasia-associated rearrangements. Cancer Res., 48: 7115-7119, 1988.
3. Mitelman, F , and Hein, S. Chromosome abnormalities in cancer. Cancer Detect. Prev , 14: 527-540, 1990.
4. Benedict, W., Sirvatasan, E., Banerjee, A., Sparker, R., and Murphree, A. Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. Cancer Res , 47: 4159-4191, 1987.
5. Cannizzaro, L. A. Gene mapping in cancer. Cancer Genet. Cytogenet., 55: 139-147, 1991
6. Yunis, J. J Multiple recurrent genomic rearrangements and fragile sites in human cancer. Somatic Cell Mol. Genet, 13. 397-403, 1987
7. Hecht, D F. Fragile sites, cancer chromosome breakpoints and oncogenes all cluster in light G bands. Cancer Genet. Cytogenet., 31: 17-20, 1988.
8. Glover, T. W., and Stein, C. K. Chromosome breakage and recombination at fragile sites. Am. J Hum. Genet., 43: 265-273, 1988.
9. Pandis, N , Bardi, G., and Heim, S. Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics. Cancer Genet. Cytogenet., 76: 77-84, 1994
10. Yeh, S-H., Chen, P-J., Chen, H-L., Lai, M-Y., Wang, C-C., and Chen, D-S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res., 54: 4188-4192, 1994.
11. Walker, G., Hayward, N., Falvey, S., and Cooksley, W. Loss of somatic heterozygosity in hepatocellular carcinomas. Cancer Res., 51: 4367-4370, 1991
12. Pasquinelli, C., Garreau, F., Bougueleret, L., Cariani, E., Grzeschik, K. H., Thiers, V., Croissant, O., Hadchocel, M., Tiollais, P., and Brechot, C Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J. Virol., 62: 629-632, 1988.
13. Zhang, W., Hirohashi, S., Tsuda, H., Shimasato, Y., Yokata, J., Terada, M., and Sugimura, T. Frequent loss of heterozygosity in chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J. Cancer Res., 81: 108-111, 1990
14. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Sato, C., Tsuruta, K., Maeda, Y., Koike, M., Tanaka, S., Nakamura, Y., Hattori, N., and Miyaki, M. Genetic changes and histopathological grades in human hepatocellular carcinomas. Jpn. J. Cancer Res., 84: 893-899, 1993.
15. Fujiwara, Y., Monden, M., Mori, T., Nakamura, Y., and Emi, M. Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res., 55: 857-860, 1993.
16. Byrne, J., Simms, L., Little, M., Algar, E., and Smith, P. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumours of the adrenal and liver. Genes Chromosomes & Cancer, 8: 104-111, 1993
17. Koufos, A., Hansen, M., Copeland, N., Jenkins, N , Lampkin, B , and Cavanee, W. Loss of heterozygosity in three embryonal tumours suggests a common pathogenic mechanism. Nature (Lond.), 316: 330-334, 1985.
18. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51: 5520-5525, 1991.
19. Tsuda, H., Zhang, W., Shimsato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., and Hirohashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci USA, 87: 6791-6794, 1990.
20. Nishida, N., Fukuda, Y., Kokurya, H., Sadamato, T., Isowa, G., Honda, K., Yamaoka, Y , Ikenaga, M., Imura, H , and Ishizaki, K. Accumulation of allelic loss on arms of human hepatocellular carcinoma. Int. J. Cancer, 57: 862-868, 1992
21. Knudson, A. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
22. Knudson, A. G., and Strong, L. C. Mutation and cancer: a model for Wilms' tumor of the kidney J. Natl. Cancer Inst., 48: 313-316, 1972.
23. Potter, V. R. A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in the rat liver. Carcinogenesis (Lond.), 2: 1375-1379, 1981.
24. Moolgavkar, S. H., and Knudson, A. G. Mutation and cancer: a model for carcinogenesis. J Natl Cancer Inst., 66: 1037-1052, 1981.
25. Hennings, H. Shores, R. Wenk, M. L , Spangler, E. F., Tarone, R., and Yupsa, S. H. Malignant conversion of mouse skin tumours is increased by tumor initiators and unaffected by tumour promoters. Nature (Lond ), 304: 67-69, 1983.
26. Scherer, E., Feringa, A W., and Emmelot, P. Initiation-promotion-initiation. Induction of neoplastic foci within islands of precancerous liver calls in the rat. In: Y. M Borzson, K. Lapis, N. E. Day, and H. Yamasaki (eds.), Models, Mechanisms, and Etiology of Tumor Promotion, pp. 57-66 IARC Scientific Publication No 56. Lyon, France: IARC. 1984.
27. Dragan, Y. P., Sargent, L., Xu, Y-D., Xu, Y-H., and Pilot, H. C. The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc. Soc Exp. Biol Med., 202: 16-24, 1993.
28. Pitot, H C , and Dragan, Y. P. Stage of tumor progression, progressor agents, and human risk. Proc. Soc. Exp. Biol. Med., 202: 27-43, 1993.
29. Fiala, S., Fiala, A., and Dixon, B. γ-Glutamyl transpeptidase in transplantable. chemically induced rat hepatomas and spontaneous mouse hepatomas. J. Natl. Cancer Inst., 48. 1393-1401, 1972.
30. Hanigan, M., and Pilot, H. C. γ-Glutamyltranspepridase - its role in hepatocarcinogenesis. Carcinogenesis (Lond.), 6. 165-172, 1985.
31. Hanigan, M , and Pitot, H. Isolation of γ-glutamyltranspeptidase positive hepatocytes during the early stages of hepatocarcinogenesis in the rat Carcinogenesis (Lond ), 3: 1349-1354, 1985.
32. Xu, Y. H., Sattler, G., and Pilot, H. A method for the comparative study of replicative DNA synthesis in GGT-positive and GGT-negative hepatocytes in primary culture from carcinogen-treated rats In Vitro Cell & Dev. Biol., 24: 995-1000, 1988.
33. Sargent, L , Xu, X. Y., Sattler, G., Meisner, L., and Pilot, H. Ploidy and karyotype of hepatocytes isolated from enzyme altered foci in two different protocols of hepatocarcinogenesis in the rat. Carcinogenesis (Lond.), 10: 387-391, 1989.
34. Sargent, L., Sattler, G., Roloff, Y., Xu, Y , Sattler, C , Meisner, L., and Pitot, H. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res., 52: 955-962, 1992.
35. Peraino, C., Staffeldt, E. G , and Ludeman, V. A. Early appearance of histochemically altered hepatocytes foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis (Lond.), 2: 463-465, 1981.
36. Pitot, H. C., Bareness, L., Goldsworthy, T., and Kitagawa, T. Biochemical characterization of the stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature (Lond.), 271 456-458, 1978.
37. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Pierotti, M. A., Della Porta, G., Binelli, G , and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis Cancer Res., 53: 209-211, 1993.
38. Albrecht, S., von Schweinitz, D., Waha, A., Kraus, J A , von Deimling, A., and Pietsch, T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoms. Cancer Res., 54: 5041-5044, 1994.
39. Fujimori, M., Tokino, T., Hino, O., Kitayawa, T., Imamura, T., Okamoto, E , Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Wakamura, Y Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51: 89-93, 1990.
40. Wang, H., and Rogler, C. Deletions in human chromosome 11p and 13q in primary hepatocellular carcinoma. Cytogenet. Cell Genet., 48: 72-78, 1988
41. Yamada, J., Kuramato, T , and Serikawa, T A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm. Genome, 5: 63-83, 1994
42. Dowdy, S. F., Fasching, C. L., Araujo, D., Lai, K-M., Livanos, E , Weissman, B. E , and Stanbridge, E. J. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11 Science (Washington DC), 254: 293-295, 1991
43. Misra, B. C , and Srivatsan, E. S Localisation of HeLa cell tumor-suppressor gene to the long arm of chromosome 11. Am. J. Hum. Genet., 45. 565-577, 1989.
44. Bystrom, C., Larsson, C., Blombert, C., Sandelin, K., Falkmer, V., Skogseid, B , Oberg, K., Werner, S., and Norderskjold, M Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors Proc Natl. Acad. Sci USA, 87: 1968-1972, 1990
45. Gatti, R. A., Berkel, I., Boder, E., Braedt, G., Charmley, P., Concannon, P., Ersoy, F., Foroud, T , Jaspers, N. G. J., Lange, K., Lathrop, G. M., Leppert, M., Nakamura, Y., O'Connell, P., Paterson, M., Salser, W., Sanal, O , Silver, J , Sparkes, R. S , Susi, E., Weeks, D. E., Wei, S , White, R , and Yoder, F Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature (Lond ), 336: 577-580, 1988.
46. Hampton, G. M , Mannermaa, A., Winquist, R., Alaraikko, M., Blanco, G., Taskinen, P J., Kiviniemi, H , Newsham, L. Cavenee, W. K., and Evans, G. A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res., 54: 4586-4589, 1994.
47. Loh, W., Scrable, H., Livanos, E., Arboleda, M. J., Cavenee, W. K., Oshimura, M., and Weissman, B. E Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc. Natl Acad. Sci., USA, 89. 1755-1759, 1992.
48. Radford, D. M., Ashley, S. W , Wells, S. A., Jr., and Gerhard, D. S. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res., 50. 6529-6533, 1990.
49. Gollahon, L. S., Chen, A , and Aldaz, C. M. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol. Carcinog., 12: 7-13, 1995
50. Bremner, R , and Balmain, A. Genetic changes in skin tumor progression, correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell, 61: 407-417, 1990.
51. Aldaz, C., Trono, D , Larcher, F., Slaga, T., and Conti, C. Sequential trisomization of chromosome 6 and 7 in mouse skin premalignant lesions. Mol. Carcinog., 2: 22-26, 1989.
52. Held, W. A., Pazik, J., O'Brien, J. G., Kerns, K., Gobey, M., Meis, R., Kenny, L , and Rustum, Y. Genetic analysis of liver tumorigenesis in SV40T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54: 6489-6495, 1994.
53. Exilie, M., Turc, C., Cheesebeuf, M., and Padieu, P. Nonrandom chromosome changes in nine liver epithelial cell lines Cell Biol. Int. Rep., 4: 459-469, 1980.
54. Haag, M., and Soukup, S. Association of chromosome 4 abnormalities with ethylnitrosourea-induced neurooncogenesis in the rat. Cancer Res., 44: 784-790, 1984.
55. Kovi, E., and Morris, H. Chromosome banding studies of several transplantable hepatomas. Adv. Enzyme Regul., 114: 139-162, 1976
56. Olah, E., and Weber, G. Giemsa-banding karyotype of rat hepatomas of different growth rates. Cancer Res., 39: 1708-1717, 1979.
57. Masuji, H. A non-random pattern in the initial chromosome aberrations in two diploid lines of rat liver cells. Gann, 65: 429-438, 1974.
58. Steadman, J , Lee, L., Smith, G , and Grisham, J DNA contents and chromosomes of transformed rat epithelial cells and of cells derived from their tumors. Carcinogenesis (Lond.), 15: 963-969, 1994
59. Coleman, W., McCullough, K , Esch, G., Civalier, C., Livanos, E., Weissman, B , Grisham, J , and Smith, G. Suppression of the tumorigenic phenotype of a rat liver epithelial cell line by the p11.2-p12 region of human chromosome 11. Mol. Carcinog., 13: 220-232, 1995.
60. Wolman, S., Horland, A., and Becker, F. Altered karyotypes of transplantable diploid tumors. J. Natl Cancer Inst , 46: 1261-1269, 1973
61. Endo, S., Nettesheim, P., Oshimura, M., and Walker, C Nonrandom chromosome alterations that correlate with progression to immortality in rat tracheal epithelial cells transformed with N-methyl-N-nitro-N-nitrosoguanidine Cancer Res , 50: 740-747, 1990.
62. Davis, L., Caspary, W., Sakallah, S., Maronpot, R., Wiseman, R., Barrett, J., Elliot, R. and Hozier, J. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis (Lond.), 15: 1637-1645, 1994.
63. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F., Dragani, T., and Pierotti, M. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23: 118-124, 1994.
64. Manenti, G., De Gregorio, L., Gariboldi, M., Dragani, T., and Pierotti, M. Analysis of loss of heterozygosity in murine hepatocellular tumors Mol Carcinog., 13: 191-200, 1995.
65. Funaki, K , Everitt, J., Bermudez, E , and Walker, C Trisomy of rat chromosome 1 associated with mesothelial cell transformation. Cancer Res , 51: 4059-4066, 1991.
66. Walker, C., Recio, L., Funaki, K., and Everitt, J Cytogenetic and molecular correlates between rodent and human renal cell carcinoma In: A. J P. Klein-Szanto, M. Anderson, and J. C. Barrett (eds ), Comparative Molecular Carcinogenesis, pp. 289-302. New York, Wiley-Liss, 1992
67. Goldsworthy, T L , Hanigan, M H., and Pitot, H C. Models of hepatocarcinogenesis in the rat - contrasts and comparisons. CRC Crit. Rev. Toxicol., 17: 61-89, 1986.